Citation

BibTex format

@article{Benns:2022:10.1038/s41564-022-01249-y,
author = {Benns, HJ and Storch, M and Falco, JA and Fisher, FR and Tamaki, F and Alves, E and Wincott, CJ and Milne, R and Wiedemar, N and Craven, G and Baragana, B and Wyllie, S and Baum, J and Baldwin, GS and Weerapana, E and Tate, EW and Child, MA},
doi = {10.1038/s41564-022-01249-y},
journal = {NATURE MICROBIOLOGY},
pages = {1891--+},
title = {CRISPR-based oligo recombineering prioritizes apicomplexan cysteines for drug discovery},
url = {http://dx.doi.org/10.1038/s41564-022-01249-y},
volume = {7},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Benns,HJ
AU - Storch,M
AU - Falco,JA
AU - Fisher,FR
AU - Tamaki,F
AU - Alves,E
AU - Wincott,CJ
AU - Milne,R
AU - Wiedemar,N
AU - Craven,G
AU - Baragana,B
AU - Wyllie,S
AU - Baum,J
AU - Baldwin,GS
AU - Weerapana,E
AU - Tate,EW
AU - Child,MA
DO - 10.1038/s41564-022-01249-y
EP - 1891
PY - 2022///
SN - 2058-5276
SP - 1891
TI - CRISPR-based oligo recombineering prioritizes apicomplexan cysteines for drug discovery
T2 - NATURE MICROBIOLOGY
UR - http://dx.doi.org/10.1038/s41564-022-01249-y
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000870624300001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 7
ER -